National and Kapodistrian University of Athens
Μελέτη των ορμονών του φύλου και των υποδοχέων τους σε μετεμμηνοπαυσιακές γυναίκες με στεφανιαία νόσο
Abstract
dc:descriptionObjectives: Long term estrogen action appears to be protective, while androgen may be detrimental for vascular health in women. The sensitivity to sex hormones is influenced by variants in estrogen and androgen receptor genes (ERα, ERβ, AR). The aim of this study was to investigate the role of the sex hormones and of common ERα, ERβ and AR gene polymorphisms in the severity of CAD in postmenopausal women. Methods: We studied 174 postmenopausal women undergoing coronary angiography (age 45-88 yrs). The severity of CAD was assessed by the number of arteries with >50% stenosis, as well as with the presence of angina and myocardial infarctions (MI). ERα polymorphisms PvuII, XbaI and ERβ polymorphisms AluΙ and RsaΙ were investigated. The length of (CAG)n repeats of the AR was genotyped. Reproductive parameters, predisposing risk factors for CAD were recorded; biochemical and hormonal parameters were measured. Results: 75 women had 0, 39 had one, 37 had two and 23 had three vessels with severe stenosis. The time since menopause was significantly longer in women with angina and MIs compared to those without (20.3±8.7 vs 15.8±8.7yrs, 22.6±8.6, vs 18.1±8.9yrs respectively, p<0.05), independently of chronological age. The age at menopause was significantly younger in women who had 2 compared to those with ?1 MI (p=0.04); the total duration of presence of menstruation was inversely related to the number of MIs (p=0.03). There was a significant association of the ERα PvuII and XbαI genotype with the severity of CAD (P=0.008, P=0.021) independently of cardiovascular risk factors. Carriers of ERβ ΑluΙ had lower adiposity and lipid parameters (p<0.04). Testosterone levels were positively and SHBG levels were negatively associated with cardiometabolic factors (p<0.04). The (CAG)n repeats of the AR ranged between 13-28. Angina, MIs, more severe CAD and antilipid drug therapy were more frequent in those carrying ?19 repeats compared to those with ?22 (p<0.04, Fisher’s exact). Cholesterol and LDL levels were negatively correlated with the (CAG)n (p=0.03). Mean SHBG levels were lower in women carrying shorter (CAG)n repeats (p=0.03). Conclusions: The severity and the clinical manifestations of CAD in postmenopausal women are inversely associated with the length of life time exposure to endogenous estrogen. Common ERα and ERβ polymorphisms which may affect tissue sensitivity to estrogen may influence the severity of CAD and/or various cardiometabolic risk factors. These findings are indicative of the protective effect of endogenous estrogen. Androgen may play an unfavorable role. Shorter polyglutamine stretch in the AR, indicative of a life-long increased androgen action, is associated with more severe CAD. These polymorphic gene variants may be taken into account in studies concerning hormonal activity in CAD and might in theory be useful early markers to predict predisposition to more severe cardiovascular disease in women.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Saltiki, Katerina
- Σαλτίκη, Αικατερίνη
Subjects
dc:subject × 20- Εμμηνόπαυση
- Στεφανιαία νόσος
- Οιστρογονικοί υποδοχείς
- Πολυμορφισμοί γονιδίου οιστρογονικού υποδοχέα
- Ανδρογονικοί υποδοχείς
- Πολυμορφισμοί γονιδίου ανδρογονικού υποδοχέα
- Αθηρωσκλήρυνση
- Καρδιαγγειακή νόσος
- Menopause
- Cardiovascular
- Atherosclerosis
- Coronary artery disease
- Estrogen receptors
- Estrogen receptor gene polymorphisms
- Androgen receptors
- Androgen receptor gene polymorphisms
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24281